Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Non-Current Liabilities: 2015-2025

Historic Total Non-Current Liabilities for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $13.6 million.

  • AC Immune's Total Non-Current Liabilities fell 10.05% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 10.05%. This contributed to the annual value of $13.6 million for FY2025, which is N/A change from last year.
  • As of Q3 2025, AC Immune's Total Non-Current Liabilities stood at $13.6 million, which was up 68,073.85% from $19,945 recorded in Q2 2025.
  • AC Immune's Total Non-Current Liabilities' 5-year high stood at $10.9 billion during Q2 2021, with a 5-year trough of $19,945 in Q2 2025.
  • In the last 3 years, AC Immune's Total Non-Current Liabilities had a median value of $9.7 million in 2023 and averaged $9.2 million.
  • As far as peak fluctuations go, AC Immune's Total Non-Current Liabilities skyrocketed by 111,294.90% in 2021, and later plummeted by 99.98% in 2022.
  • AC Immune's Total Non-Current Liabilities (Quarterly) stood at $10.2 million in 2021, then crashed by 44.57% to $5.7 million in 2022, then soared by 70.78% to $9.7 million in 2023, then tumbled by 99.79% to $20,325 in 2024, then declined by 10.05% to $13.6 million in 2025.
  • Its Total Non-Current Liabilities was $13.6 million in Q3 2025, compared to $19,945 in Q2 2025 and $19.0 million in Q1 2025.